Table 1.
Variable | PD (n = 19) | Healthy controls (n = 10) |
p- value |
---|---|---|---|
Age (years) | 66.6 ± 8.9 | 65.3 ± 7.3 | .70 |
Sex (female/male, n) | 5/14 | 7/3 | .03* |
Education (years) | 17.5 ± 2.8 | 17.3 ± 3.9 | .84 |
Handedness (R/L, n) | 19/0 | 10/0 | N/A |
Cognitive status (MoCA score) | 27.3 ± 1.4 | 27.6 ± 2.3 | .69 |
Disease duration (years) | 5.7 ± 3.0 | N/A | N/A |
MDS-UPDRS II | 11.5 ± 6.8 | N/A | N/A |
MDS-UPDRS III | 30.9 ± 11.5 | N/A | N/A |
Modified H & Y scale | 2.1 ± .4 | N/A | N/A |
LED | 749.3 ± 370.9 | N/A | N/A |
SCOPA-AUT | 15.5 ± 6.6 | N/A | N/A |
Note: PD = Parkinson’s disease; R/L = Right/Left; MoCA = Montreal Cognitive Assessment; MDS-UPDRS = Movement Disorder Society Unified Parkinson Disease Rating Scale; H &Y = Hoehn and Yahr; LED = Levodopa Equivalent Dose; SCOPA-AUT = Scales for Outcomes in Parkinson's Disease-Autonomic questionnaire; N/A = Not Applicable. The results are presented as mean ± standard deviation except for the sex variable.
Significant value (p < .05).